A prospective study of nearly 3000 patients with solid tumors treated at Mayo over the last couple of years reported 6.4% had clinically actionable mutations detected with a universal testing approach that would not have been detected by phenotype or family history–based testing criteria. | Samadder, JAMA Oncol 2020


  1. This is such a great resource that you are providing and you give it away for free. I love seeing blog that understand the value of providing a quality resource for free kubet


Post a Comment

Popular Posts